Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants

中和 抗体 病毒学 贪婪 表位 生物 重链 2019年冠状病毒病(COVID-19) 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 恢复期血浆 中和抗体 病毒 免疫学 医学 传染病(医学专业) 疾病 病理
作者
Jianliang Xu,Kai Xu,Seolkyoung Jung,A. Conte,Jenna Ariel Lieberman,Frauke Muecksch,Julio C. C. Lorenzi,Solji Park,Fabian Schmidt,Zijun Wang,Yaoxing Huang,Yang Luo,Manoj S. Nair,Pengfei Wang,Jonathan E. Schulz,Lino Tessarollo,Tatsiana Bylund,Gwo‐Yu Chuang,Adam S. Olia,Tyler Stephens,I‐Ting Teng,Yaroslav Tsybovsky,Tongqing Zhou,Vincent J. Munster,David D. Ho,Théodora Hatziioannou,Paul D. Bieniasz,Michel C. Nussenzweig,Peter D. Kwong,Rafael Casellas
出处
期刊:Nature [Nature Portfolio]
卷期号:595 (7866): 278-282 被引量:174
标识
DOI:10.1038/s41586-021-03676-z
摘要

Abstract Since the start of the COVID-19 pandemic, SARS-CoV-2 has caused millions of deaths worldwide. Although a number of vaccines have been deployed, the continual evolution of the receptor-binding domain (RBD) of the virus has challenged their efficacy. In particular, the emerging variants B.1.1.7, B.1.351 and P.1 (first detected in the UK, South Africa and Brazil, respectively) have compromised the efficacy of sera from patients who have recovered from COVID-19 and immunotherapies that have received emergency use authorization 1–3 . One potential alternative to avert viral escape is the use of camelid VHHs (variable heavy chain domains of heavy chain antibody (also known as nanobodies)), which can recognize epitopes that are often inaccessible to conventional antibodies 4 . Here, we isolate anti-RBD nanobodies from llamas and from mice that we engineered to produce VHHs cloned from alpacas, dromedaries and Bactrian camels. We identified two groups of highly neutralizing nanobodies. Group 1 circumvents antigenic drift by recognizing an RBD region that is highly conserved in coronaviruses but rarely targeted by human antibodies. Group 2 is almost exclusively focused to the RBD–ACE2 interface and does not neutralize SARS-CoV-2 variants that carry E484K or N501Y substitutions. However, nanobodies in group 2 retain full neutralization activity against these variants when expressed as homotrimers, and—to our knowledge—rival the most potent antibodies against SARS-CoV-2 that have been produced to date. These findings suggest that multivalent nanobodies overcome SARS-CoV-2 mutations through two separate mechanisms: enhanced avidity for the ACE2-binding domain and recognition of conserved epitopes that are largely inaccessible to human antibodies. Therefore, although new SARS-CoV-2 mutants will continue to emerge, nanobodies represent promising tools to prevent COVID-19 mortality when vaccines are compromised.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ly发布了新的文献求助10
刚刚
刚刚
笋尖266发布了新的文献求助10
1秒前
1秒前
落后的士萧完成签到,获得积分20
1秒前
2秒前
fly完成签到,获得积分10
2秒前
小二郎应助Clarence采纳,获得10
2秒前
专注的小松鼠完成签到,获得积分10
2秒前
Ava应助沉静缘分采纳,获得20
2秒前
柔弱的兔子完成签到,获得积分10
3秒前
3秒前
3秒前
辣味尖尖酱完成签到,获得积分10
3秒前
enchanted完成签到,获得积分10
4秒前
苏生鑫发布了新的文献求助10
4秒前
倪倪完成签到,获得积分10
4秒前
苯妥英俊完成签到,获得积分10
4秒前
奥格诺完成签到,获得积分10
5秒前
甜甜亦巧发布了新的文献求助20
6秒前
zl完成签到,获得积分20
6秒前
6秒前
6秒前
鹏大鹏发布了新的文献求助10
6秒前
椰树椰汁完成签到,获得积分10
6秒前
7秒前
煜琪发布了新的文献求助10
7秒前
7秒前
啦啦啦发布了新的文献求助10
7秒前
7秒前
Neptune完成签到,获得积分10
8秒前
zcbb完成签到,获得积分10
8秒前
111完成签到,获得积分10
8秒前
Shan完成签到 ,获得积分10
9秒前
笑点低千雁完成签到,获得积分10
9秒前
9秒前
脑洞疼应助怕黑的纸鹤采纳,获得10
10秒前
廖紊完成签到,获得积分10
10秒前
万幸鹿发布了新的文献求助10
10秒前
11秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969033
求助须知:如何正确求助?哪些是违规求助? 3513900
关于积分的说明 11170818
捐赠科研通 3249256
什么是DOI,文献DOI怎么找? 1794708
邀请新用户注册赠送积分活动 875326
科研通“疑难数据库(出版商)”最低求助积分说明 804759